[WebMD]

TUESDAY, April 15, 2014 (HealthDay News) — A new blood test may one day help predict the recurrence of breast cancer and also a woman’s response to breast cancer treatment, researchers report.

“We are able to do this with literally a spoonful of serum [blood],” said study co-author Saraswati Sukumar, who is co-director of the breast cancer program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, in Baltimore.

Once a patient’s blood is collected, the researchers isolate circulating tumor DNA. The genetics test then detects any of 10 breast cancer-specific genes that have undergone what experts call hypermethylation.

In the hypermethylation process, the activity of some genes that keep cancers in check is turned off, and that may signal a return of the cancer.

READ MORE

Leave a comment

Your email address will not be published.

Yes, I would like to receive emails from Washington Informer Newspaper. Sign me up!


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, https://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact